Breztri Aerosol, Metered
Pricing Report NDC 0310-4616-12

Current NADAC: $61.28234 per GM · Effective Aug 19, 2026

Current Package Pricing Information

The current wholesale acquisition cost for Breztri (NDC 0310-4616-12) is $61.28234 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2026.

As a a human prescription drug provided by Astrazeneca Pharmaceuticals Lp, this medication is distributed in a 120 AEROSOL, METERED in 1 INHALER configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$61.28234
Per GM

Effective Date
Aug 19, 2026
Data Status
As of Sep 09, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
120 AEROSOL, METERED in 1 INHALER
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Dec 2020, the NADAC wholesale price for (NDC ) has moved within a range of $53.06078 to $61.44949 per GM. Over this 5 years and 7 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$53.0608 - $61.3126
Market Volatility
15.55% Variance
Latest Trend
0.05%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $61.28234 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Aug 19, 2026 $61.38644 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jul 22, 2026 $61.31261 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jul 22, 2026 $61.28333 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jun 17, 2026 $61.30817 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jun 17, 2026 $61.44949 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
May 20, 2026 $61.30272 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jan 01, 2026 $61.25613 GMC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Jan 01, 2026 $61.25613 GMC/I - Chain or Independent PharmacyCode 3, 5B - Brand
Jan 01, 2026 $61.25613 GMC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Jan 01, 2026 $61.16006 GMC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Jan 01, 2026 $61.16006 GMC/I - Chain or Independent PharmacyCode 3, 5B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026